Afinitor to be added to the PBS
I am pleased to let you know that the breast cancer drug Afinitor (everolimus) will be added to the PBS on 1 June this year.
Afinitor is a drug for women with hormone-receptor positive, HER2-negative secondary breast cancer. It is used with Aromasin (exemestane) when the breast cancer has stopped responding to hormone therapy alone.
Afinitor is a tablet, so doesn't have many of the side effects of IV chemotherapy (which is the alternative treatment). It also means you can take it at home, instead of having to go to a hospital or oncology unit.
Afinitor has been available in Australia since 2012, but has not been listed on the PBS. We know some women are already receiving treatment with it.
Take care everyone,